DataMEDS AI, Inc. MEDS · NASDAQ
$2.23 -3.04% (-$0.07)
- Market cap
- $7.04M
- Enterprise value
- $37.2M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 0.9x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -439.9%
- Gross margin
- -125.1%
- Net margin
- -1,100.3%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- -1.52
- Free float
- 34.3%
About the company
TRxADE HEALTH, Inc. (MEDS) is an American company operating in the healthcare technology sector, focusing on the development and operation of a platform for electronic trading of pharmaceuticals and healthcare products. This platform connects pharmacies, distributors, and drug manufacturers, enabling efficient and transparent purchasing and selling of healthcare products. TRxADE HEALTH aims to improve the distribution and availability of medications and provide tools to simplify business operations within the healthcare industry. Investors interested in technological innovations in healthcare and enhancements in the distribution chain might see potential in TRxADE HEALTH, Inc. (MEDS) shares for growth in this sector.
Sector
Healthcare
Industry
Medical - Distribution
CEO
Prashant Patel
Employees
31
Headquarters
Tampa
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number